Background: Numerous studies have reported the relationship between sleep duration and obesity in elderly adults; however, little is known about the relationship of sleep duration and sarcopenia. Objective: We examined the relationship of sleep duration with obesity and sarcopenia in community-dwelling older adults. Methods: A total of 488 community-dwelling adults (224 men and 264 women) aged ≥65 years were included in the analysis. Self-reported sleep duration and anthropometric data were collected. Skeletal muscle mass was estimated using the predicted equation from a bioelectrical impedance analysis measurement. Obesity and sarcopenia were defined according to the body mass index and the skeletal muscle mass index, respectively. Results: The association between sleep duration and sarcopenia exhibited a U shape in older adults. Compared to adults with 6-8 h of sleep, adults with <6 h of sleep had a nearly 3-fold increased likelihood of sarcopenia (odds ratio, OR: 2.76, 95% confidence interval, CI: 1.28-5.96), while adults with ≥8 h of sleep had a nearly 2-fold increased risk of sarcopenia (OR: 1.89, 95% CI: 1.01-3.54). Older adults with a sleep duration <6 h were more prone to obesity (OR: 2.15, 95% CI: 1.08−4.30). After gender stratification, the association between obesity and short sleep duration was more robust in women. Conclusion: There were significant associations of sleep duration with either obesity or sarcopenia in community-dwelling older adults. Gender differences in these associations were also observed.

Keywords:
Sarcopenia, Sleep duration, Obesity, Older adults, Gender differences
1.
Ancoli-Israel S, Cooke JR: Prevalence and comorbidity of insomnia and effect on functioning in elderly populations. J Am Geriatr Soc 2005;53:S264-S271.
2.
Cappuccio FP, D'Elia L, Strazzullo P, Miller MA: Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010;33:585-592.
3.
Ohayon MM: Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002;6:97-111.
4.
Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR: Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2005;59:131-136.
5.
Wu MC, Yang YC, Wu JS, Wang RH, Lu FH, Chang CJ: Short sleep duration associated with a higher prevalence of metabolic syndrome in an apparently healthy population. Prev Med 2012;55:305-309.
6.
Chaput JP, Despres JP, Bouchard C, Astrup A, Tremblay A: Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analysis of the Quebec Family Study. Sleep Med 2009;10:919-924.
7.
Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, Hu FB: A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 2003;163:205-209.
8.
Tamakoshi A, Ohno Y, Group JS: Self-reported sleep duration as a predictor of all-cause mortality: results from the JACC study, Japan. Sleep 2004;27:51-54.
9.
Chen HC, Su TP, Chou P: A nine-year follow-up study of sleep patterns and mortality in community-dwelling older adults in Taiwan. Sleep 2013;36:1187-1198.
10.
International Working Group on Sarcopenia: Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. J Am Med Dir Assoc 2011;14:249-256.
11.
Baumgartner RN: Body composition in healthy aging. Ann N Y Acad Sci 2000;904:437-448.
12.
Haslam DW, James WP: Obesity. Lancet 2005;306:1197-1209.
13.
Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS: Sarcopenia. J Lab Clin Med 2001;137:231-243.
14.
Melton LJ III, Khosla S, Crowson CS, O'Connor MK, O'Fallon WM, Riggs BL: Epidemiology of sarcopenia. J Am Geriatr Soc 2000;48:625-630.
15.
Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD: Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755-763.
16.
Janssen I, Heymsfield SB, Ross R: Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatric Soc 2002;50:889-896.
17.
Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R: Skeletal muscle cutpoints association with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159:413-421.
18.
Lang PO, Michel JP, Zekry D: Frailty syndrome: a transitional state in a dynamic process. Gerontology 2009;55:539-549.
19.
Taheri S, Lin L, Austin D, Young T, Mignot E: Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004;1:e62.
20.
Marshall NS, Glozier N, Grunstein RR: Is sleep duration related to obesity? A critical review of the epidemiological evidence. Sleep Med Rev 2008;12:289-298.
21.
Fex A, Barbat-Artigas S, Dupontgand S, Filion ME, Karelis AD, Aubertin-Leheudre M: Relationship between long sleep duration and functional capacities in postmenopausal women. J Clin Sleep Med 2012;8:309-313.
22.
Chien MY, Kuo HK, Wu YT: Sarcopenia, cardiopulmonary fitness, and physical disability in community-dwelling elderly. Phys Ther 2010;90:1277-1287.
23.
Chien MY, Chen HC: Poor sleep quality is independently associated with physical disability in older adults. J Clin Sleep Med 2014, Epub ahead of print.
24.
Sallis JF, Haskell WL, Wood PD, Fortmann SP, Rogers T, Blair SN, Paffenbarger RS Jr: Physical activity assessment methodology in Five-City Project. Am J Epidemiol 1985;121:91-106.
25.
Buysse DJ, Reynolds III CF, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
26.
Tsai PS, Wang SY, Wang MY, Su CT, Yang TT, Huang CJ, Fang SC: Psychometric evaluation of the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI) in primary insomnia and control subjects. Qual Life Res 2005;14:1943-1952.
27.
Lukaski HC, Bolonchuk WW, Hall CB, Siders WA: Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 1986;60:1327-1332.
28.
Pollock ML, Graves JE, Mahar MT: Reliability and validity of bioelectrical impedance in determining body composition. J Appl Physiol 1988;64:529-534.
29.
Janssen I, Heymsfield SB, Baumgartner RN, Ross R: Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000;89:465-471.
30.
D'Ath P, Katona P, Mullan E, Evans S, Katona C: Screening, detection and management of depression in elderly primary care attenders. I: The acceptability and performance of the 15 item Geriatric Depression Scale (GDS15) and the development of short versions. Fam Pract 1994;11:260-266.
31.
Kempen GI, Miedema I, Omiel J, Molenaar W: The assessment of disability with the Groningen Activity Restriction Scale: conceptual framework and psychometric properties. Soc Sci Med 1996;43:1601-1610.
32.
Rao MN, Blackwell T, Redline S, Stefanick ML, Ancoli-Israel S, Stone KL; Osteoporotic Fractures in Men (MrOS) Study Group: Association between sleep architecture and measures of body composition. Sleep 2009;32:483-490.
33.
Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB: Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 2005;28:1289-1296.
34.
Magee CA, Caputi P, Iverson DC: Is sleep duration associated with obesity in older Australian adults? J Aging Health 2010;22:1235-1255.
35.
Magee CA, Iverson DC, Caputi P: Sleep duration and obesity in middle-aged Australian adults. Obesity 2010;18:420-421.
36.
Hasler G, Buysse DJ, Klaghofer R, Gamma A, Ajdacic V, Eich D, Rössler W, Angst J: The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep 2004;27:661-666.
37.
Cappuccio FP, Taggart FM, Kandala NB, Currie A, Peile E, Stranges S, Miller MA: Meta-analysis of short sleep duration and obesity in children and adults. Sleep 2008;31:619-626.
38.
Cournot M, Ruidavets JB, Marquie JC, Esquirol Y, Baracat B, Ferrières J: Environmental factors associated with body mass index in a population of Southern France. Eur J Cardiovasc Prev Rehabil 2004;11:291-297.
39.
Yi S, Nakagawa T, Yamamoto S, Mizoue T, Takahashi Y, Noda M, Matsushita Y: Short sleep duration in association with CT-scanned abdominal fat areas: the Hitachi Health Study. Int J Obes 2012;37:129-134.
40.
Patel SR, Blackwell T, Redline S Ancoli-Israel S, Cauley JA, Hillier TA, Lewis CE, Orwoll ES, Stefanick ML, Taylor BC, Yaffe K, Stone KL; Osteoporotic Fractures in Men Research Group; Study of Osteoporotic Fractures Research Group: The association between sleep duration and obesity in older adults. International J Obes 2008;32:1825-1834.
41.
van den Berg JF, Knvistingh Neven A, Tulen JH, Hofman A, Witteman JC, Miedema HM, Tiemeier H: Actigraphic sleep duration and fragmentation are related to obesity in the elderly: the Rotterdam Study. Int J Obes (Lond) 2008;32:1083-1090.
42.
López-García E, Faubel R, León-Muñoz L, Zuluaga MC, Banegas JR, Rodríguez-Artalejo F: Sleep duration, general and abdominal obesity, and weight change among the older adult population of Spain. Am J Clin Nutr 2008;87:310-316.
43.
van den Berg JF, van Rooij FJA, Vos H, Tulen JH, Hofman A, Miedema HM, Neven AK, Tiemeier H: Disagreement between subjective and actigraphic measures of sleep duration in population-based study of elderly persons. J Sleep Res 2008;17:295-302.
44.
Seidell JC, Visscher TL: Body weight and weight change and their health implications for the elderly. Eur J Clin Nutr 2000;54(suppl 3):S33-S39.
45.
Allison DB, Faith MS, Heo M, Kotler DP: Hypothesis concerning the U-shaped relation between body mass index and mortality. Am J Epidemiol 1997;146:339-349.
46.
Bliwise DL, Young TB: The parable of parabola: what the U-shaped curve can and cannot tell us about sleep. Sleep 2007;30:1614-1615.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.